Gilead Sciences, Inc.'s (JOBS) 2nd-Quarter Profit Rises 31 Percent On Sales Of HIV Drugs Atripla, Truvada

Silicon Valley / San Jose Business Journal -- Gilead Sciences Inc. on Tuesday reported second quarter net income of $571.4 million, or 61 cents a share, up from $434.8 million, or 45 cents a share in the same period last year.